+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank

Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank

Journal of Bone and Mineral Research 19(10): 1689-1697

We report the first case of lethal autosomal recessive osteopetrosis in mice caused by a spontaneous 8-bp deletion in exon 2 of the Rank gene. The phenotype, including a block in RANKL-dependent osteoclast differentiation and lymph node agenesis, copies that of Rank-/- mice, which have been produced by targeted recombination. Introduction: Commitment of osteoclast progenitors to the osteoclast lineage requires RANKL/RANK-mediated intercellular signals. Gene-targeted defects in this signaling pathway resulted in osteoclast deficiency and severe osteopetrosis in mice, but to date, there have been no reports of spontaneous mutations in Rankl or Rank resulting in osteopetrosis. Materials and Methods: Mice with malignant osteopetrosis and absent lymph nodes appeared spontaneously in a highly inbred colony. Appropriate crosses were analyzed to establish the pattern of inheritance. Tissues from affected pups and littermates were evaluated grossly, histopathologic ally, and radiographically. Osteoclast development from splenocytes was tested in vitro under a variety of conditions, including after infection with RANK-encoding retrovirus. Rank mutational analysis was performed by direct sequencing of RT-PCR products and genomic DNA. Results: The inheritance pattern was consistent with autosomal recessive inheritance, and the phenotype resembled that of either Rankl or Rank knockout mice with the exception of as yet unexplained death of most mice 2-3 weeks after weaning. Osteoclast precursors from the spleens of affected pups failed to form osteoclasts in vitro when stimulated with macrophage-colony stimulating factor (M-CSF) and RANKL, unless they were forced to express wildtype Rank cDNA. Molecular genetic studies identified an 8-bp deletion in exon 2 of the Rank gene. The resulting allele, termed Rankdel8, encodes only a small portion of the RANK extracellular domain, which is probably nonfunctional. Conclusions: The phenotypic similarities between Rankdel8 and mice previously described with a combined insertion and deletion in Rank confirm the role of this receptor in osteoclastogenesis and lymph node development and suggest that some forms of malignant osteopetrosis in humans could result from a similar defect.

(PDF emailed within 0-6 h: $19.90)

Accession: 012283776

Download citation: RISBibTeXText

PMID: 15355564

DOI: 10.1359/JBMR.040713

Related references

Mutation screening for autosomal recessive malignant osteopetrosis. Journal of Medical Genetics 39(Supplement 1): S64, September, 2002

Identification of novel mutation in autosomal recessive infantile malignant osteopetrosis. Indian Journal of Pediatrics 81(9): 969-970, 2016

Osteoclast morphology in autosomal recessive malignant osteopetrosis due to a TCIRG1 gene mutation. Pediatric Pathology & Molecular Medicine 22(1): 3-9, 2003

Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation. Human Molecular Genetics 7(9): 1407-1410, 1998

Long-term survival in infantile malignant autosomal recessive osteopetrosis secondary to homozygous p.Arg526Gln mutation in CLCN7. American Journal of Medical Genetics. Part A 158a(4): 909-916, 2012

RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations. Journal of Bone and Mineral Research 27(2): 342-351, 2012

RANK-dependent autosomal recessive osteopetrosis characterisation of 5 new cases with novel mutations. 2011

Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients. Osteoporosis International 27(3): 1047-1055, 2015

The mutational spectrum of human malignant autosomal recessive osteopetrosis. Human Molecular Genetics 10(17): 1767-1773, 2001

Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcified Tissue International 84(1): 1-12, 2009

A novel CLCN7 mutation resulting in a most severe form of autosomal recessive osteopetrosis. European Journal of Pediatrics 168(12): 1449-1454, 2010

Novel mutations in Indian patients with autosomal recessive infantile malignant osteopetrosis. Indian Journal of Medical Research 131(): 508-514, 2010

The Use of Whole Exome Sequencing for the Diagnosis of Autosomal Recessive Malignant Infantile Osteopetrosis. Clinical Genetics: -, 2016

Optic nerve compression in infantile malignant autosomal recessive osteopetrosis. Journal of Pediatric Ophthalmology and Strabismus 41(4): 241-244, 2004

A newly described mutation of the CLCN7 gene causes neuropathic autosomal recessive osteopetrosis in an Arab family. Clinical Dysmorphology 21(1): 1-7, 2012